Active — Not RecruitingNot Applicable

Diagnostic Accuracy of Fluorodeoxyglucose-18 PET in the Evaluation of RPTC With Patient's Raised Thyroglobulin Level

Pakistan39 participantsStarted 2025-03-17

Plain-language summary

This research will employ cross-sectional analytical to determine diagnostic accuracy of Flourodeoxyglucose-18 Positron Emission Computed Tomography in the evaluation of Recurrent Papillary Thyroid Carcinoma with patient's raised Thyroglobulin level in Lahore.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients include both male and female from 18years to 80years * Patients presented with raised thyroglobulin * Patients with suspected diagnosis of recurrent papillary thyroid carcinoma Exclusion Criteria: * Patients exclude both male and female below 18years and above 80years * All the patients presented with carcinoma other than papillary carcinoma. * All the patients with normal thyroglobulin level.

What they're measuring

Nominal self admsinitered questioner

Timeframe: 12 Months

Trial details

NCT IDNCT07062211

SponsorSuperior University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-09-01

View on ClinicalTrials.gov More Papillary Thyroid Carcinoma trials